1 Min Read
Dec 22 (Reuters) - Zhejiang Medicine Co Ltd :
* Says it decided to terminate clinical trials for a kind of antitumor drug (R&D code name of XC302)
Source text in Chinese: goo.gl/MTcbAZ
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.